International network for comparison of HIV neutralization assays: the NeutNet report II.

International network for comparison of HIV neutralization assays: the NeutNet report II.

Neutralizing antibodies provide markers for vaccine-induced protective immunity in many viral infections. By analogy, HIV-1 neutralizing antibodies induced by immunization may well predict vaccine effectiveness. Assessment of neutralizing antibodies is therefore of primary importance, but is hampere...

Full description

Bibliographic Details
Main Authors:	Leo Heyndrickx, Alan Heath, Enas Sheik-Khalil, Jose Alcami, Vera Bongertz, Marianne Jansson, Mauro Malnati, David Montefiori, Christiane Moog, Lynn Morris, Saladin Osmanov, Victoria Polonis, Meghna Ramaswamy, Quentin Sattentau, Monica Tolazzi, Hanneke Schuitemaker, Betty Willems, Terri Wrin, Eva Maria Fenyö, Gabriella Scarlatti
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3348930?pdf=render

Similar Items

International network for comparison of HIV neutralization assays: the NeutNet report II.
by: Heyndrickx, L, et al.
Published: (2012)

International network for comparison of HIV neutralization assays: the NeutNet report.
by: Eva Maria Fenyö, et al.
Published: (2009-01-01)

International network for comparison of HIV neutralization assays: the NeutNet report.
by: Fenyo, E, et al.
Published: (2009)

Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
by: Scarlatti, G, et al.
Published: (2009)

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
by: Polonis V, et al.
Published: (2009-10-01)

Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group
by: Scarlatti, G, et al.
Published: (2008)

Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer
by: Sara J. Felts, et al.
Published: (2015-04-01)

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.
by: Leo Heyndrickx, et al.
Published: (2013-01-01)

Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.
by: Cornelissen, B, et al.
Published: (2014)

SCA-1 Identifies the Tumor-Initiating Cells in Mammary Tumors of BALB-neuT Transgenic Mice
by: Cristina Grange, et al.
Published: (2008-12-01)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
by: Heyndrickx L, et al.
Published: (2012-09-01)

Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children
by: Stefania Dispinseri, et al.
Published: (2021-03-01)

The Potential Role of Neutrophil-Reactive Intensity (NEUT-RI) in the Diagnosis of Sepsis in Critically Ill Patients: A Retrospective Cohort Study
by: Elena Maria Alessandra Mantovani, et al.
Published: (2023-05-01)

PD-L1NEUT, Foxp3Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma
by: Lin Zhou PhD, et al.
Published: (2021-09-01)

Testing charged current quasi-elastic and multinucleon interaction models in the NEUT neutrino interaction generator with published datasets from the MiniBooNE and MINERνA experiments
by: Wilkinson, C, et al.
Published: (2016)

Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01)

A combination of broadly neutralizing antibodies prevents in vitro SHIV162p3 cell-free transmission more efficiently than cell to cell transmission
by: K. Suphaphiphat, et al.
Published: (2016-05-01)

P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
by: Schuitemaker H, et al.
Published: (2009-10-01)

A new classification for HIV-1.
by: Berger, E, et al.
Published: (1998)

Comparative immunogenicity of HIV-1 clade C envelope proteins for prime/boost studies.
by: Douglas H Smith, et al.
Published: (2010-08-01)

A combination of broad neutralizing antibodies efficiently protects from in vitro cell-associated SHIV162P3 transmission
by: Karunasinee Suphaphiphat, et al.
Published: (2018-05-01)

Vertical human immunodeficiency virus type 1 - HIV-1 -transmission - a review
by: Vera Bongertz
Published: (2001-01-01)

Electrical Synapses Enhance and Accelerate Interneuron Recruitment in Response to Coincident and Sequential Excitation
by: Pepe Alcami, et al.
Published: (2018-06-01)

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
by: Manuela Pogliaghi, et al.
Published: (2015-01-01)

Antibody-based HIV-1 vaccines: recent developments and future directions
by: Montefiori, D, et al.
Published: (2007)

Antibody-based HIV-1 vaccines: recent developments and future directions.
by: Montefiori, D, et al.
Published: (2007)

The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques.
by: Yufei Wang, et al.
Published: (2012-01-01)

Cathal Doyle et Jill Cariño, Les Peuples autochtones et les industries extractives. Mettre en œuvre le Consentement, libre, préalable et informé
by: Sandrine Tolazzi

Ressources minières et énergétiques : le choc des discours
by: Sandrine Tolazzi

Entretien avec Mme Bernadette Mérenne-Schoumaker, Professeur honoraire de géographie économique et de didactique de la géographie à l’Université de Liège
by: Sandrine Tolazzi

Making Fort McMurray Home: Space and Place on Canada’s New Frontier of Oil Production
by: Sandrine Tolazzi

La prise en compte des savoirs traditionnels autochtones dans les projets de développement des ressources minières et énergétiques au Canada : perspectives et limites
by: Sandrine TOLAZZI

Alternative Possibilities for Defining the Length of the Separate Left-Turn Lane at the Existing Level Intersection
by: Tomaž Tolazzi
Published: (2002-01-01)

The Contribution to the Procedure of Capacity Determination at Unsignalized Priority-controlled Intersections
by: Tomaž Tolazzi
Published: (2004-01-01)

Virus phenotype variability during disease progression of HIV-1 infected children
by: Fenyö Eva-Maria, et al.
Published: (2008-04-01)

Control of Mycoplasma contamination in hybridoma technology
by: Vera Bongertz, et al.
Published: (1988-06-01)

Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaques.
by: Emma J Bowles, et al.
Published: (2014-01-01)

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
by: Bin Su, et al.
Published: (2019-12-01)

Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
by: Karunasinee Suphaphiphat, et al.
Published: (2020-07-01)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
by: Aaby P, et al.
Published: (2009-10-01)